Wednesday - July 02, 2025

Category Archives: Marketing & Sales

Xole AI Transforms AI Image Generation with Innovative Multi-Model Integration Platform

AI Team Introduces Comprehensive Image-to-Image Transformation Platform Xole AI, an artificial intelligence startup, recently introduced its platform focused on AI image generation. The company, comprised of a specialized team of AI technology professionals, has developed a comprehensive platform that integrates … Continue reading →

Bronchial Hyperreactivity Market to Reach New Heights in Growth by 2032, DelveInsight Predicts | Sumitomo Pharma America, Syntara, AstraZeneca, GlaxoSmithKline

The Key Bronchial Hyperreactivity Companies in the market include – Rambam Health Care Campus, Sumitomo Pharma America, Inc., Syntara, AstraZeneca, GlaxoSmithKline, and others.   DelveInsight’s “Bronchial Hyperreactivity Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the … Continue reading →

Lung Fibrosis Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Bristol-Myers Squibb, Boehringer Ingelheim, Pfizer, Zambon SpA, Centocor

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Lung Fibrosis pipeline constitutes key companies continuously working towards developing Lung Fibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →

CTD-ILD Market Growth Projections 2024-2034: DelveInsight Analysis | GlaxoSmithKline, Actelion, Prometheus Biosciences, Eric Matteson, Genentech, Inc., Boehringer Ingelheim

The Key CTD-ILD Companies in the market include – GlaxoSmithKline, Actelion, Prometheus Biosciences, Eric Matteson, Genentech, Inc., Boehringer Ingelheim Pharmaceuticals, and others.   DelveInsight’s “CTD-ILD Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the CTD-ILD, historical … Continue reading →

Cough in Idiopathic Pulmonary Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Algernon Pharma, Seyltx, Melius Pharma, NeRRe Therapeutics, Trevi Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Cough in Idiopathic Pulmonary Fibrosis pipeline constitutes 5+ key companies continuously working towards developing 5+ Cough in Idiopathic Pulmonary Fibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, … Continue reading →

Progressive pulmonary fibrosis Market on Track for Major Expansion by 2034According to DelveInsight | Bristol-Myers Squibb, Avalyn Pharma Inc., Boehringer Ingelheim, United Therapeutics, Sunshine Lake

The Key Progressive pulmonary fibrosis Companies in the market include – Boehringer Ingelheim, Bristol-Myers Squibb, Avalyn Pharma Inc., United Therapeutics, Sunshine Lake Pharma, Endeavor Biomedicines, and others.   The Progressive pulmonary fibrosis market is expected to surge due to the … Continue reading →